Vir Biotechnology (VIR) Change in Acquisitions & Divestments (2018 - 2026)

Vir Biotechnology's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $170.6 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 43.48% year-over-year to $170.6 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 26.09% YoY), while the FY2025 annual figure was $1.2 billion, down 30.91% from the prior year.
• Change in Acquisitions & Divestments came in at $170.6 million for Q1 2026 at Vir Biotechnology, down from $342.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $715.7 million in Q4 2023 to a low of $84.8 million in Q3 2022.
• A 5-year average of $377.6 million and a median of $342.9 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 427.69% in 2023 and sank 57.93% in 2024, its largest moves.
• Vir Biotechnology's Change in Acquisitions & Divestments stood at $266.7 million in 2022, then surged by 168.39% to $715.7 million in 2023, then slumped by 57.93% to $301.1 million in 2024, then climbed by 13.88% to $342.9 million in 2025, then tumbled by 50.25% to $170.6 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $170.6 million, $342.9 million, and $305.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison